BioVentrix has announced the first clinical use in the Netherlands of its closed-chest Revivent transcatheter (TC) ventricular enhancement system. The less invasive ventricular enhancement (LIVE) procedure was performed by cardiothoracic surgeon Patrick Klein and by interventional cardiologist Pierfrancesco Agostoni at the St Antonius Hospital (Nieuwegein, The Netherlands).
A press release reports that the device was successfully implanted with four micro-anchor pairs in a 56-year-old male patient with ischaemic heart failure. The procedure reshaped the left ventricle and decreased the left ventricular end systolic volume index. By remodelling the left ventricule to a more normal shape and size, the implant is designed to improve pumping efficiency, decrease wall stress, and immediately reverse patients’ symptoms.
Agostoni comments: “We are excited to be the first centre in the Netherlands to implant the Revivent TC System. We achieved a sizable reduction in the patient’s left ventricular volume and he will see significant improvement in his symptoms. The LIVE procedure is clearly less invasive and provides an important sense of control when operating on the beating heart.”